Literature DB >> 1516503

Sensory function at diagnosis and in early stages of NIDDM in patients detected through screening.

J M Sosenko1, M Kato, R Soto, R B Goldberg.   

Abstract

OBJECTIVE: We studied whether sensory function abnormalities are present at diagnosis and whether they develop in the early stages of non-insulin-dependent diabetes (NIDDM). RESEARCH DESIGN AND METHODS: Quantitative assessments of vibration sensitivity at the hallux and index fingers, and thermal sensitivity at the hallux were performed at screening (2-h oral glucose tolerance tests) for diabetes in 364 individuals. Twenty-five subjects diagnosed with NIDDM and 25 matched nondiabetic subjects were restudied after an interval of 12-41 mo.
RESULTS: When those with NIDDM (n = 41) or impaired glucose tolerance (IGT) (n = 38) were compared with nondiabetic subjects, there were no significant differences in sensory function indices. However, the vibration threshold and HbA1c were related among those found to be hyperglycemic (IGT and NIDDM combined P less than 0.05; NIDDM alone P less than 0.05). Among diabetic subjects, the vibration threshold and interaction term of height and Hba1c were positively related in a multiple regression analysis (P less than 0.01). There were increments in all sensory thresholds in diabetic patients at follow-up (P less than 0.05 for all). Increments were smaller in control subjects.
CONCLUSIONS: These data suggest that although sensory function tends to be normal at diagnosis in NIDDM patients, there appears to be a diminution in sensory function as the disease progresses. An interaction between metabolic factors and height may influence sensory function early in the course of NIDDM.

Entities:  

Mesh:

Year:  1992        PMID: 1516503     DOI: 10.2337/diacare.15.7.847

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  4 in total

1.  Reproducibility of peroneal motor nerve conduction measurement in older adults.

Authors:  Rachel E Ward; Robert M Boudreau; Aaron I Vinik; Sasa A Zivkovic; Omer T Njajou; Suzanne Satterfield; Tamara B Harris; Anne B Newman; Elsa S Strotmeyer
Journal:  Clin Neurophysiol       Date:  2012-09-26       Impact factor: 3.708

2.  Peripheral neuropathy defined by monofilament insensitivity and diabetes status: NHANES 1999-2004.

Authors:  Jodie G Katon; Gayle E Reiber; Karin M Nelson
Journal:  Diabetes Care       Date:  2012-12-28       Impact factor: 19.112

3.  Advances in the diagnosis and management of diabetic distal symmetric polyneuropathy.

Authors:  Jacek Kasznicki
Journal:  Arch Med Sci       Date:  2014-05-13       Impact factor: 3.318

4.  Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors.

Authors:  Jackie Elliott; Solomon Tesfaye; Nish Chaturvedi; Rajiv A Gandhi; Lynda K Stevens; Celia Emery; John H Fuller
Journal:  Diabetes Care       Date:  2009-07-08       Impact factor: 17.152

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.